HealthCare Institute of New Jersey
HINJ is a trade association (founded 1997) representing research-based biopharmaceutical and medical technology companies in New Jersey. The organization conducts policy advocacy and legislative monitoring, operates statewide patient-access and assistance programs, organizes industry events and coalitions, provides member services, and publishes economic and programmatic analyses to support the life sciences innovation ecosystem in New Jersey.
Industries
Nr. of Employees
small (1-50)
HealthCare Institute of New Jersey
Services
State and federal advocacy, legislative monitoring, stakeholder briefings and policy position development for life sciences issues.
Central online portal aggregating hundreds of prescription assistance programs to connect eligible patients with no-cost or low-cost medications.
Formation and management of multi-stakeholder coalitions to promote innovation policy, industry-academia collaboration, and grassroots advocacy.
Organizing summits, panels and educational forums to connect industry leaders, policymakers and academic partners.
Tiered membership management, committee participation, regular policy briefings and networking opportunities.
Preparing media kits, public statements, press outreach and hosting organizational news and updates.
State and federal advocacy, legislative monitoring, stakeholder briefings and policy position development for life sciences issues.
Central online portal aggregating hundreds of prescription assistance programs to connect eligible patients with no-cost or low-cost medications.
Formation and management of multi-stakeholder coalitions to promote innovation policy, industry-academia collaboration, and grassroots advocacy.
Organizing summits, panels and educational forums to connect industry leaders, policymakers and academic partners.
Tiered membership management, committee participation, regular policy briefings and networking opportunities.
Preparing media kits, public statements, press outreach and hosting organizational news and updates.
Expertise Areas
- Policy advocacy and regulatory engagement
- Patient access program management
- Industry coalition and partnership development
- Economic impact analysis and reporting
Key Technologies
- Digital patient assistance portals
- Online membership and dues management platforms
- Legislative and policy tracking tools
- Economic and workforce data analysis
News & Updates
Organizational statement by HINJ leadership regarding the retirement of Rep. Bonnie Watson Coleman.
Organizational statement responding to a federal announcement on weight-loss drug policy.
Op-ed by HINJ leadership addressing state construction and infrastructure investments related to life sciences.
Rx4NJ (central portal for prescription assistance programs) has served over 300,000 New Jersey patients since inception.
HINJ founded as a trade association to represent New Jersey life sciences companies.
Organizational statement by HINJ leadership regarding the retirement of Rep. Bonnie Watson Coleman.
Organizational statement responding to a federal announcement on weight-loss drug policy.
Op-ed by HINJ leadership addressing state construction and infrastructure investments related to life sciences.
Rx4NJ (central portal for prescription assistance programs) has served over 300,000 New Jersey patients since inception.
HINJ founded as a trade association to represent New Jersey life sciences companies.